Health-system and regulatory watchers brace for new FDA and HHS actions as mifepristone, vaccines, and psychedelic medicine dominate policy debate
Federal health officials prepare new FDA and HHS actions in 2024 amid debates on mifepristone, vaccines, and psychedelic medicine policies.
Read More